Yondelis granted orphan drug status by Swissmedic

被引：0

|

作者：

不详

机构：

来源：

EJHP PRACTICE | 2008年 / 14卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：14 / 14

页数：1

相关论文

共 50 条

[1] Oncophage® granted orphan drug status by US FDA
不详
[J]. EXPERT REVIEW OF VACCINES, 2009, 8 (06) : 660 - 660
[2] Oncophage® granted orphan drug status by US FDA
不详
[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (06) : 786 - 786
[3] Orphan drug status granted to trovert, spheramine, apomorphine
不详
[J]. BIOTECHNOLOGY LAW REPORT, 1997, 16 (5-6): : 554 - 555
[4] New TB vaccine granted orphan drug status
Lang, T
Hill, AVS
McShane, H
Shah, R
Towse, A
Pritchard, C
Garau, M
[J]. BRITISH MEDICAL JOURNAL, 2005, 331 (7530): : 1476 - 1476
[5] Pharmaceuticals -: Anagrelide granted orphan status
不详
[J]. CHEMISTRY & INDUSTRY, 2001, (02) : 34 - 34
[6] MP-470 granted orphan drug designation
不详
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1373 - 1373
[7] Anti-CD20 monoclonal antibody granted orphan drug status for CLL in USA
不详
[J]. EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (05) : 525 - 525
[8] Reports Isavuconazole Granted Orphan Drug Designation by US FDA
不详
[J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (04) : II - II
[9] Daratumumab granted breakthrough drug status
Laubach, Jacob P.
Tai, Yu-Tzu
Richardson, Paul G.
Anderson, Kenneth C.
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (04) : 445 - 452
[10] GalioMedix and Orphan Drug Status
不详
[J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (03) : 16N - 16N

← 1 2 3 4 5 →